Consumer Financial Protection Bureau staff told to work remotely as headquarters is shuttered

Office of Management and Budget (OMB) Acting Director Russell Vought speaks with reporters during a press briefing at the White House in Washington, U.S., March 11, 2019.

Jonathan Ernst | Reuters

Consumer Financial Protection Bureau employees were told Sunday to work remotely because their Washington, D.C., headquarters would be closed through Feb. 14, according to a memo obtained by CNBC.

The memo, from CFPB Chief Operating Officer Adam Martinez, follows an email sent Saturday from newly installed acting CFPB director Russell Vought which instructed staff to suspend nearly all activities of the regulator, including supervising financial firms.

This story is developing. Please check back for updates.

Source

Coinbase joining S&P 500 days after bitcoin soared past 0,000

Finance

Coinbase joining S&P 500 days after bitcoin soared past $100,000

May 12, 2025

Key Points Coinbase is joining the S&P 500, replacing Discover Financial, which is being acquired. Shares of the crypto exchange soared in extended trading after the announcement. Bitcoin eclipsed the $100,000 market last week, approaching its record reached in January. Source

Finance

After UK and China trade deals, tariff rate still highest since 1934, Yale report says

May 12, 2025

Key Points The average effective tariff rate on imports is 17.8%, the highest since 1934, even after trade deals reached with China and the U.K. in recent days, according to the Yale Budget Lab. Levies that President Trump placed on other products and countries still remain, including a 10% tariff on almost all trading partners. […]

Finance

Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more

May 12, 2025

Check out the companies making headlines in midday trading: Drugmakers — Pharmaceutical stocks bounced back from earlier losses after an executive order aimed at bringing down drug prices was deemed not as bad as feared for the industry. Merck jumped 5%, while Pfizer , Bristol-Myers Squibb and Eli Lilly all rose more than 2%. However, […]